Results for trileptal translation from English to Chinese (Simplified)

the trileptal.
影响。

trileptal®(oxcarbazepine)
曲莱®（奥卡西平）

eurap provided a cumulative list of trileptal associated cases to novartis in september 2012.
eurap在2012年9月为诺华公司提供了一份奥卡西平用药病例的统计表。

there were a total of 63 serious cases received for trileptal from the eurap registry.
在eurap登记中心共收到63例关于奥卡西平的严重不良事件。

the reference documents for the drug safety profile of trileptal (oxcarbazepine) are:
trileptal（奥卡西平）的药物安全性的参考文件有：

of the 69 abortion cases, 23 cases were reported with trileptal monotherapy and 46 cases reported with polytherapy.
在69例流产病例中，23例为奥卡西平单一药物治疗，46例为多种药物治疗。

trileptal is indicated as a first-line antiepileptic medicinal product for use as monotherapy or adjunctive therapy.
奥卡西平还适用于癫痫的单一治疗和辅助治疗，属于一线抗癫痫药物。

the current novartis cds already informs prescribers and patients of the pregnancy risks associated with trileptal and the considerations for minimizing risks.
目前诺华公司的cds已经通知了医生和病人奥卡西平治疗的怀孕风险和关于风险最小化的考虑。

the causal association of hip dysplasia for the two cases with trileptal monotherapy cannot be established or ruled out due to limited information precluding medical assessment.
因为有限的医疗信息和无相关医疗评估，这两例髋关节发育不良的病例无法与奥卡西平单一药物治疗建立相关性。

of these 145 cases, 96 cases were reported with polytherapy and 49 cases were reported with monotherapy (trileptal).
这145例病例中，96例未多种药物治疗癫痫，49例为单一药物治疗。

the pharmacological activity of trileptal (oxcarbazepine) is primarily exerted through the metabolite (10-monohydroxy derivative, mhd) of oxcarbazepine.
trileptal（奥卡西平）的药理活性主要是通过代谢物（10-单羟基衍生物，mhd）来实现的。

the impact of the newly entered serious events into argus is assessed by placing these reports into context with the overall cumulative number of post-marketing reports in argus for trileptal (oxcarbazepine) in table 4-6.
对新输入argus的严重不良事件的影响进行评估，将这些报告加入公司曲莱（奥卡西平）上市后的总体统计数据库中进行比较，见表4-6。